Thalidomide Induces Haematologic Responses in Patients with β‐Thalassaemia
ConclusionIn this study, thalidomide showed an outstanding effect on β‐thalassaemia patients who required frequent red‐cell transfusions. Thalidomide increased haemoglobin levels without causing serious adverse reactions, but the long‐term curative outcomes and other side effects should be observed continuously.This article is protected by copyright. All rights reserved.
Source: European Journal of Haematology - Category: Hematology Authors: Jiangming Chen, Weijian Zhu, Ning Cai, Shengdi Bu, Jinyan Li, Lan Huang Tags: Original Article Source Type: research
More News: Laboratory Medicine | Study